World Small-scale Bioreactors Market Analysis Report 2023-2030: Use of Small-scale Bioprocessing Systems in Upstream Processing, Parallel Processing, and Experiment Evaluation Bolsters Demand - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Small-scale Bioreactors Market Size, Share & Trends Analysis Report By Capacity, By Product (Reusable, Single-use), By End-user (CROs & CMOs, Pharma & Biopharma Companies), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global small-scale bioreactors market size is expected to reach USD 5.05 billion by 2030, registering a CAGR of 14.8%

The product has a high demand and the market is anticipated to grow rapidly as a result of the COVID-19 pandemic. The pandemic has increased the need for research on cell-based drug discovery and also the demand for manufacturing novel medicines and vaccines according to the size of the population.

For instance, according to the World Health Organization's 2022 report, vaccine research has accelerated to an unprecedented pace in response to the COVID-19 pandemic and approximately 11.25 billion vaccine doses had been given around the globe as of 4 April 2022.

Moreover, the use of small-scale bioprocessing systems in upstream processing, parallel processing, and experiment evaluation for bioprocess optimization is expected to drive the demand for small-scale bioreactors in process development.

Revenues in the bioprocessing technology industry have increased as a result of COVID-19. Thus, the development of a SARS-CoV-2 vaccine has progressed quickly, according to all major suppliers. In addition, the demand for bioprocessing technologies had also grown as a result of a rise in vaccine R&D.

The desire for COVID-19 was cited by company executives as a key driver. Furthermore, the strong demand for small-scale bioreactors is being driven by the recent increase in COVID-19-related research and development between several biotech and pharmaceutical companies.

Furthermore, the growth of the market during the forecast period is fueled by the rise in technical development and advancements in equipment design for bioprocessing. The sales of small-scale bioreactors are also expected to increase as a result of an increase in product launches and the expansion of product lines by several manufacturers.

For instance, in October 2022, Froilabo expanded its line of temperature-controlled laboratory equipment by introducing a new collection of completely automated lab-scale bioprocessing systems.

Small-scale Bioreactors Market Report Highlights

• The reusable bioreactors segment held the largest share in 2022 owing to the higher need for reusable bioreactors in the pharmaceutical and biopharmaceutical industries for cost-effective manufacturing
• The 1L-3L capacity segment accounted for the largest revenue share in 2022 due to the wide-scale availability of bioreactors with a working volume capacity of 1L-3L in small-scale production
• The CROs & CMOs end-user segment held the largest share in 2022. Since these companies have adopted novel single-use bioreactors much more quickly than therapeutic manufacturers, they have contributed to a larger revenue share
• North America was the dominant regional market in 2022 due to the presence of several global players and growing investments from public & private organizations for proteomic and life science research in the region

Market Dynamics

Market Driver Analysis

• Increasing research & development activities in the biopharmaceutical industry
• Highly competitive market and various strategies undertaken by market players
• Increasing demand for single use small-scale bioreactors

Market Restraint Analysis

• Limitations of small-scale bioreactors

Industry Analysis Tools

• SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
• Porter's Five Forces Analysis
• Penetration and Growth Prospect Mapping, 2022

COVID-19 Impact Analysis

Competitive Landscape

• Sartorius AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corporation
• Lonza Group
• Eppendorf AG
• Miltenyi Biotec
• Getinge AB
• Solaris Biotechnology Srl
• Infors AG

For more information about this report visit https://www.researchandmarkets.com/r/74cfge

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900